Replies to post #31407 on Cat House

[Porgie Tirebiter]

Wow, it's had quite a run-up. They're on track to lose $5.28/share in 2017. CFRA has a $100 price target on it.

I think it's a lot more likely to go down than it is up?

Last couple weeks, I've been writing puts in CELG at around the $100 level. It's on track to make $7.33/share in 2017. Stock got killed in October when they lowered guidance in the 3Q conference call. CFRA gives it 5 stars and a $140 price target.

It may be a little safer a play if you want to be in the pharmaceutical sector??